Home/Filings/4/0001213900-21-031447
4//SEC Filing

Albanna Rowena 4

Accession 0001213900-21-031447

CIK 0001726711other

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 4:05 PM ET

Size

5.0 KB

Accession

0001213900-21-031447

Insider Transaction Report

Form 4
Period: 2021-06-04
Albanna Rowena
CHIEF OPERATING OFFICER
Transactions
  • Award

    Common Stock

    2021-06-04+75,000826,620 total(indirect: See Footnote)
Footnotes (2)
  • [F1]The restricted common stock vests in three (3) successive equal annual installments, which began on March 31, 2021.
  • [F2]Held beneficially by the husband of the Reporting Person.

Documents

1 file

Issuer

Aditx Therapeutics, Inc.

CIK 0001726711

Entity typeother

Related Parties

1
  • filerCIK 0001818598

Filing Metadata

Form type
4
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 4:05 PM ET
Size
5.0 KB